Profile data is unavailable for this security.
About the company
AdaptHealth Corp. is a provider of patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. It operates in 50 states through its network of over 670 locations in 47 states.
- Revenue in USD (TTM)3.25bn
- Net income in USD78.62m
- Incorporated2017
- Employees10.50k
- LocationAdapthealth Corp555 East North Lane, Suite 5075CONSHOHOCKEN 19428United StatesUSA
- Phone+1 (610) 424-4515
- Fax+1 (302) 636-5454
- Websitehttps://adapthealth.com/investor-relations/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STAAR Surgical Co | 279.13m | -71.08m | 869.68m | 1.16k | -- | 2.48 | -- | 3.12 | -1.44 | -1.44 | 5.63 | 7.07 | 0.5877 | 1.67 | 5.34 | 241,256.70 | -14.97 | 3.81 | -17.36 | 4.42 | 74.00 | 77.03 | -25.46 | 5.42 | 4.07 | -- | 0.00 | 0.00 | -2.64 | 15.89 | -194.66 | -- | 18.11 | -- |
| Inmode Ltd | 392.41m | 175.78m | 961.41m | 599.00 | 6.55 | 1.67 | 5.45 | 2.45 | 2.32 | 2.32 | 5.12 | 9.13 | 0.4916 | 1.36 | 11.99 | 655,105.20 | 22.02 | 28.05 | 24.10 | 31.28 | 80.03 | 83.39 | 44.80 | 40.99 | 7.86 | -- | 0.00 | 0.00 | -19.76 | 20.35 | -8.41 | 24.28 | -0.7024 | -- |
| Pulse Biosciences Inc | 0.00 | -60.24m | 1.03bn | 75.00 | -- | 8.70 | -- | -- | -0.9691 | -0.9691 | 0.00 | 1.76 | 0.00 | -- | -- | 0.00 | -66.00 | -83.75 | -71.00 | -94.40 | -- | -- | -- | -12,644.52 | 15.58 | -- | 0.00 | -- | -- | -- | -26.95 | -- | -27.12 | -- |
| Integra Lifesciences Holdings Corp | 1.62bn | -28.96m | 1.05bn | 4.40k | -- | 0.6894 | 8.86 | 0.6468 | -0.3767 | -0.3767 | 21.18 | 19.61 | 0.3995 | 1.59 | 6.58 | 369,496.80 | -0.7122 | 2.90 | -0.838 | 3.25 | 58.47 | 62.59 | -1.78 | 7.14 | 0.7206 | 2.98 | 0.5474 | 0.00 | 4.47 | 1.20 | -110.25 | -- | -3.19 | -- |
| BioLife Solutions Inc | 94.24m | -7.62m | 1.08bn | 159.00 | -- | 3.07 | 7,514.00 | 11.48 | -0.1658 | -0.2297 | 2.03 | 7.42 | 0.2366 | 0.992 | 6.79 | 592,729.60 | -1.91 | -1.92 | -2.09 | -2.10 | 62.64 | 52.54 | -8.09 | -9.06 | 3.74 | -1.06 | 0.0354 | -- | 8.44 | 24.62 | 38.27 | -- | 19.15 | -- |
| Neogen Corp | 906.00m | -485.26m | 1.14bn | 2.92k | -- | 0.4267 | -- | 1.25 | -2.24 | -2.24 | 4.18 | 12.26 | 0.2102 | 2.39 | 5.43 | 310,591.70 | -11.26 | 1.38 | -11.67 | 1.44 | 48.79 | 48.23 | -53.56 | 4.31 | 2.45 | 0.88 | 0.2513 | 0.00 | 12.37 | 17.41 | 58.81 | -- | 50.02 | -- |
| Tandem Diabetes Care Inc | 982.95m | -183.87m | 1.14bn | 2.65k | -- | 7.32 | -- | 1.16 | -2.78 | -2.78 | 14.96 | 2.33 | 1.06 | 3.18 | 8.96 | 370,924.90 | -19.74 | -10.11 | -26.61 | -12.33 | 52.22 | 51.67 | -18.71 | -11.71 | 1.81 | -- | 0.6953 | -- | 25.74 | 21.01 | 56.86 | -- | 27.42 | -- |
| Adapthealth Corp | 3.25bn | 78.62m | 1.26bn | 10.50k | 16.21 | 0.8065 | 2.70 | 0.3895 | 0.5779 | 0.5779 | 23.91 | 11.62 | 0.7262 | 20.92 | 7.66 | 309,177.20 | 2.01 | -2.81 | 2.29 | -3.17 | 23.35 | 19.63 | 2.77 | -4.19 | 1.07 | 2.24 | 0.5596 | -- | 1.90 | 43.84 | 112.19 | -- | 70.36 | -- |
| Establishment Labs Holdings Inc | 170.24m | -89.10m | 1.28bn | 1.03k | -- | 33.27 | -- | 7.54 | -3.10 | -3.10 | 5.94 | 1.33 | 0.536 | 0.7032 | 2.98 | 167,225.00 | -28.06 | -31.53 | -34.39 | -39.32 | 66.35 | 65.46 | -52.34 | -45.09 | 2.05 | -2.41 | 0.8511 | -- | 0.5292 | 13.14 | -7.76 | -- | 17.33 | -- |
| BioSig Technologies Inc | 26.00k | -9.79m | 1.32bn | 5.00 | -- | 89.83 | -- | 50,612.27 | -0.6236 | -0.6236 | 0.0016 | 0.1118 | 0.0087 | -- | 0.4228 | 5,200.00 | -323.76 | -266.73 | -- | -392.02 | 50.00 | -- | -37,400.00 | -20,163.95 | -- | -1,551.13 | 0.00 | -- | 122.22 | -- | 63.81 | -- | -- | -- |
| Artivion Inc | 390.08m | -21.36m | 1.32bn | 1.60k | -- | 4.48 | 561.78 | 3.38 | -0.5102 | -0.5102 | 9.31 | 6.89 | 0.4953 | 1.72 | 4.81 | 243,802.50 | -2.72 | -2.47 | -2.90 | -2.66 | 63.94 | 65.02 | -5.49 | -5.89 | 3.95 | 0.8589 | 0.5197 | -- | 9.75 | 7.06 | 56.37 | -- | 6.75 | -- |
| Evolent Health Inc | 2.40bn | -140.48m | 1.38bn | 4.50k | -- | 1.45 | -- | 0.5741 | -1.22 | -1.22 | 20.86 | 9.74 | 0.9057 | -- | 5.59 | 533,052.70 | -4.11 | -5.93 | -5.59 | -8.00 | 15.25 | 21.07 | -4.54 | -7.16 | -- | 0.276 | 0.4206 | -- | 30.09 | 30.04 | 34.31 | -- | -6.87 | -- |
| Omnicell Inc | 1.14bn | 21.18m | 1.40bn | 3.62k | 65.92 | 1.11 | 12.73 | 1.23 | 0.4521 | 0.4521 | 24.39 | 26.84 | 0.5122 | 6.62 | 4.54 | 309,470.00 | 0.9553 | 1.07 | 1.24 | 1.40 | 43.24 | 45.58 | 1.87 | 1.93 | 1.23 | -- | 0.2135 | 0.00 | -3.04 | 4.39 | 161.51 | -27.21 | -3.06 | -- |
| AtriCure Inc | 480.08m | -38.18m | 1.55bn | 1.30k | -- | 3.42 | -- | 3.24 | -0.8101 | -0.8101 | 10.19 | 9.19 | 0.8115 | 1.65 | 8.09 | 369,289.20 | -6.45 | -3.84 | -7.20 | -4.25 | 74.76 | 74.53 | -7.95 | -7.13 | 2.88 | -21.61 | 0.1335 | -- | 16.55 | 15.05 | -46.85 | -- | 14.00 | -- |
| 10X Genomics Inc | 624.66m | -157.04m | 1.60bn | 1.31k | -- | 2.27 | -- | 2.56 | -1.30 | -1.30 | 5.15 | 5.74 | 0.6841 | 2.50 | 8.68 | 478,301.70 | -17.20 | -25.61 | -19.51 | -29.19 | 68.36 | 74.03 | -25.14 | -47.52 | 4.68 | -- | 0.00 | -- | -1.28 | 19.96 | 28.41 | -- | -20.72 | -- |
| Alphatec Holdings Inc | 642.27m | -165.54m | 1.60bn | 867.00 | -- | -- | -- | 2.49 | -1.15 | -1.15 | 4.45 | -0.4243 | 0.8234 | 1.23 | 7.01 | 740,790.10 | -21.22 | -27.43 | -26.85 | -34.69 | 68.96 | 66.99 | -25.77 | -39.40 | 1.67 | -11.66 | 1.13 | -- | 26.81 | 40.07 | 13.14 | -- | 48.19 | -- |
Data as of Jul 03 2025. Currency figures normalised to Adapthealth Corp's reporting currency: US Dollar USD
46.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2025 | 14.75m | 10.93% |
| The Vanguard Group, Inc.as of 31 Mar 2025 | 11.99m | 8.89% |
| Reinhart Partners LLCas of 31 Mar 2025 | 7.24m | 5.37% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2025 | 6.56m | 4.87% |
| Segall Bryant & Hamill LLCas of 31 Mar 2025 | 4.75m | 3.53% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 4.39m | 3.25% |
| Dimensional Fund Advisors LPas of 31 Mar 2025 | 4.02m | 2.98% |
| Jefferies LLCas of 31 Mar 2025 | 3.94m | 2.92% |
| Palisade Capital Management LPas of 31 Mar 2025 | 2.71m | 2.01% |
| Geode Capital Management LLCas of 31 Mar 2025 | 2.57m | 1.90% |
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
